Menu
Meet the Program Commitee for 2022!
Program Committee
-
Petra Doerr, PharmD, RPh
•
Director
European Directorate for the Quality of Medicines and Healthcare (EDQM), France -
Sini Eskola, MPharm, MS, MSc
•
Director Regulatory Strategy
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Marco Greco, PhD
•
President
European Patients' Forum, Belgium -
Sabine Haubenreisser, PhD, MSc
•
Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Niklas Hedberg, MPharm
•
HTACG Co-Chair & Chief Pharmacist
Dental and Pharmaceutical Benefits Agency, TLV, Sweden -
Volker Liebenberg
•
Chief Medical Officer
Elypta, Sweden -
Alan Morrison, PhD
•
Vice President Regulatory Affairs Intl
MSD, United Kingdom -
Karen A Noonan, MA
•
Senior Vice President, Global Regulatory Policy
Association of Clinical Research Organizations (ACRO), United States -
Sibilia Quilici
•
Executive Director
Vaccines Europe, Belgium -
Tim Buchanan
•
Senior Director, Clinical Lead, Tau, Neurology Patient Value Unit
UCB Biopharma, Belgium -
Manuel Haas, PharmD, MSc
•
Executive Director - Regulatory Affairs Europe
MSD UK, United Kingdom -
Rebecca Stanbrook, RPh
•
EFPIA ICH E6(R3) Expert Working Group Member
Switzerland -
Matt Popkin, PhD
•
Senior Director, CMC Excellence, Global Regulatory Affairs
GSK, United Kingdom -
Diane Wilkinson, PhD, RPh
•
Executive Director, Global CMC Regulatory Affairs
AstraZeneca, United Kingdom -
Thomas Brookland, MSc
•
EU Data and AI Policy Lead
F. Hoffmann-La Roche Ltd, Switzerland -
Douglas Gregory
•
Senior Director, Government Affairs Strategy and Excellence
Belgium -
Ronnie Harprit Mundair
•
Regional Labelling Head - AfME, Canada and LATAM - Senior Director
Pfizer, United Kingdom -
Rodrigo Palacios, MBA
•
Executive Director, Technical Regulatory Policy
F. Hoffmann-La Roche, Switzerland -
Henrik K. Nielsen, PhD, MBA, MSc
•
Vice President
Novo Nordisk A/S, Denmark -
Isabelle Stoeckert, PharmD, PMP
•
VP. Head Regulatory Affairs Europe Middle East Africa
Bayer, Germany -
Álmath Spooner, PhD
•
Head of Europe Regulatory Policy & Intelligence (RPI)
Abbvie, Ireland -
Raphael Van Eemeren
•
EU QPPV Director, Global Patient Safety
Amgen AB, Sweden -
Alison Cave, PhD
•
Chief Safety Officer
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Patrice Verpillat, DrMed, MD, PhD, MPH
•
Head of Real World Evidence
European Medicines Agency, Netherlands -
Rick Vreman
•
Patient Access Manager
Roche, Netherlands -
Nadege Le Roux, PhD
•
Regulatory Policy Senior Director
Bristol Myers Squibb, Switzerland -
Andras Incze
•
Founder & CEO, Akceso Advisors AG, Switzerland
University Lecturer Healthcare Management, B-W State University, Germany, Switzerland -
Piers Mahon
•
Senior Principal and European Leader
Oncology Evidence Networks, IQVIA, United Kingdom -
Bettina Ryll
•
Member of the First EU Cancer Mission Board
MPNE, Vision Zero Cancer, Sweden